These inhibitors generally hinder the phosphorylation of several protein kinases of membrane receptors, such as vascular endothelial growth factor receptors, platelet-derived growth factor receptors, the human epidermal growth factor receptor family, and cytoplasmic receptors such as c-Kit, Raf kinase, and FLT3.
These inhibitors include ZD6474, SU11248, AEE 788, sorafenib, vatalanib, and AG-013736.
.
